DNL747 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

---

臨床試験数 : 645 /  薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03757351 (ClinicalTrials.gov)	December 14, 2018	27/11/2018	Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis	A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL747 in Subjects With Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	Drug: DNL747;Drug: Placebo	Sanofi	Denali Therapeutics Inc.	Terminated	21 Years	80 Years	All	15	Phase 1	United States;Netherlands